The Chemours Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -455.00 M

The Chemours Company Operating Cash Flow is USD -455.00 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -218.18% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • The Chemours Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 385.00 M, a -39.18% change year over year.
  • The Chemours Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 633.00 M, a -19.16% change year over year.
  • The Chemours Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 783.00 M, a -2.37% change year over year.
  • The Chemours Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 802.00 M, a 8.67% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities